- Home
- EDN vs INVA Comparison
EDN vs INVA Comparison
Compare EDN & INVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
N/A
Current Price
$19.98
Company Overview
Basic Information| Metric | EDN | INVA |
|---|---|---|
| Founded | 1992 | 1996 |
| Country | Argentina | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.5B |
| IPO Year | 2007 | 2004 |
Fundamental Metrics
Financial Performance| Metric | EDN | INVA |
|---|---|---|
| Price | $30.67 | $19.98 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $36.80 |
| AVG Volume (30 Days) | 77.9K | ★ 638.5K |
| Earning Date | 03-10-2026 | 02-25-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 53.96 |
| EPS | 0.08 | ★ 1.52 |
| Revenue | ★ $1,678,118,877.00 | $388,521,000.00 |
| Revenue This Year | $32.93 | $13.23 |
| Revenue Next Year | $24.64 | $8.58 |
| P/E Ratio | $19.30 | ★ $12.85 |
| Revenue Growth | 3.69 | ★ 10.14 |
| 52 Week Low | $14.38 | $16.52 |
| 52 Week High | $40.64 | $22.76 |
Technical Indicators
Market Signals| Indicator | EDN | INVA |
|---|---|---|
| Relative Strength Index (RSI) | 56.97 | 53.08 |
| Support Level | $26.05 | $19.29 |
| Resistance Level | $29.75 | $19.80 |
| Average True Range (ATR) | 1.61 | 0.50 |
| MACD | 0.19 | 0.05 |
| Stochastic Oscillator | 96.40 | 80.49 |
Price Performance
Historical Comparison EDN
INVA
About EDN Empresa Distribuidora Y Comercializadora Norte S.A. (Edenor)
Empresa Distribuidora y Comercializadora Norte SA is engaged in the distribution and sale of electricity. The firm's concession area covers the northern portion of the city of Buenos Aires mainly to residential, commercial, industrial, and public service.
About INVA Innoviva Inc.
Innoviva Inc is a company with a portfolio of royalties healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.